Ausgabe 2/2004
Inhalt (10 Artikel)
One hundred years of cancer research
Basic science going clinical: molecularly targeted therapy of chronic myelogenous leukemia
Michael W. N. Deininger
Induction of differentiation and peroxisome proliferator-activated receptor γ expression in colon cancer cell lines by troglitazone
Masashi Kato, Tomomi Kusumi, Shigeki Tsuchida, Masanori Tanaka, Mutsuo Sasaki, Hajime Kudo
Immunohistochemical determination of HER-2/neu, c-Kit (CD117), and vascular endothelial growth factor (VEGF) overexpression in malignant melanoma
Anil Potti, Nauman Moazzam, Eric Langness, Kaley Sholes, Ketki Tendulkar, Michael Koch, Steve Kargas
Clinical value of biliary alkaline phosphatase in non-jaundiced cholangiocarcinoma
Vajarabhongsa Bhudhisawasdi, Kanha Muisuk, Premjai Areejitranusorn, Churairat Kularbkaew, Tueanjit Khampitak, O-Tur Saeseow, Sopit Wongkham
Report of a user-satisfaction analysis of a service provider for an oncology clinic
Michael Hartmann, Holger Knoth, Daniel Kühne
Cytochrome P450 (CYP) 1A2, sulfotransferase (SULT) 1A1, and N-acetyltransferase (NAT) 2 polymorphisms and susceptibility to urothelial cancer
Hiromasa Tsukino, Yoshiki Kuroda, Hiroyuki Nakao, Hirohisa Imai, Hisato Inatomi, Yukio Osada, Takahiko Katoh
Biweekly CHOP or THP-COP regimens in the treatment of newly diagnosed aggressive non-Hodgkin’s lymphoma
Hisashi Tsurumi, Toshiki Yamada, Michio Sawada, Senji Kasahara, Nobuhiro Kanemura, Yasushi Kojima, Kenji Fukuno, Takeshi Hara, Masanao Saio, Takeshi Takahashi, Masami Oyama, Keiya Ozawa, Tsuyoshi Takami, Hisataka Moriwaki
The coexistence of ERBB2, INT2, and CMYC oncogene amplifications and PTEN gene mutations in endometrial carcinoma
Bożena Konopka, Aneta Janiec-Jankowska, Zygmunt Paszko, Marian Goluda
Gemcitabine-induced vasculitis in advanced transitional cell carcinoma of the bladder
M. Birlik, S. Akar, E. Tuzel, F. Onen, E. Ozer, M. Manisali, Z. Kirkali, N. Akkoc